chrisvoncsefalvay/vaers-outcomes huggingface dataset:
General ill feeling; cough; Malaise; depressed; Fatigue; Joint pain; Chills; Local pain at the injection site; Wave of ill feeling in his lower throat (below the voice box); This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), FEELING ABNORMAL (General ill feeling), COUGH (cough), MALAISE (Malaise) and DEPRESSION (depressed) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Insomnia, GERD, Hypertension, Atrial fibrillation, Dyslipidemia and Allergic rhinitis. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Atrial fibrillation, AMLODIPINE for Blood pressure high, FENOFIBRATE for Dyslipidemia, BISOPROLOL for Hypertension, ZOLPIDEM for Insomnia.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), MALAISE (Malaise), DEPRESSION (depressed), FATIGUE (Fatigue), ARTHRALGIA (Joint pain), CHILLS (Chills) and VACCINATION SITE PAIN (Local pain at the injection site). On an unknown date, the patient experienced FEELING ABNORMAL (General ill feeling) and COUGH (cough). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Wave of ill feeling in his lower throat (below the voice box)), FEELING ABNORMAL (General ill feeling), COUGH (cough), FATIGUE (Fatigue), ARTHRALGIA (Joint pain) and CHILLS (Chills) outcome was unknown and MALAISE (Malaise), DEPRESSION (depressed) and VACCINATION SITE PAIN (Local pain at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: No specific follow-up information recorded.
Patient called pharmacy 5/2/13 to state she had a red strip that appeared to be an allergy around the injection site, about 2 inches in length. No other adverse reactions reported.
dry heaves; chest pain; heart attack; Sweats and chills the next morning; Sweats and chills the next morning; tiredness; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm on 29Mar2021 17:45 (Batch/Lot Number: EP1534) as SINGLE DOSE for covid-19 immunization.  Medical history reported as "none before this event".  Patient previously received the first dose of BNT162B2 (lot number: EN6203) on 08Mar2021 17:45 in the left arm for covid-19 immunization. The patient's concomitant medications were not reported. The patient experienced sweats and chills the next morning, tiredness, then went to dry heaves and chest pain after 2:30 PM -- on 30Mar2021 all these side effects started from early morning and at 5:30 went to ER and was told he was having a heart attack. The patient underwent lab tests and procedures on 30Mar2021, which included Covid (sars-cov-2) test with negative results.  The outcome of events was reported as "not recovered". Therapeutic measures were taken as a result of the events includes angiogram and stent on right side of heart. The events were considered as serious since events involved inpatient hospitalization and persistent or significant disability or incapacity.  No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.
This case was reported by a pharmacist and described the occurrence of mental status changes in a subject of unspecified age and gender who was vaccinated with influenza virus vaccine (Influenza vaccine, manufacturer unspecified) for prophylaxis. There were no concurrent medications. On an unspecified date before 15, February 2007, the subject received unspecified dose of Influenza vaccine. At an unspecified time after vaccination with Influenza vaccine. On an unspecified date on or before 15, February 2007, the subject experienced mental status changes. At the time of initial reporting, 15, February 2007, the event was ongoing
Information has been received from a physician concerning a 17 year old female patient who on 22-SEP-2006 was vaccinated IM with a first 0.5 ml dose of HPV rL1 6 11 16 18 VLP vaccine (yeast). There was no concomitant medication. On 22-SEP-2006 the patient developed swollen lymph nodes in the neck and groin, swelling at injection site and low grade fever. The patient sought unspecified medical attention. It was reported that the patient was recovering. Additional information has been requested.
This case was reported by a physician and described the occurrence of extensive swelling of vaccinated limb in a 35-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included penicillin allergy. On 12 November 2013 the subject received 2nd dose of ENGERIX B (1ml/ 20 mcg, unknown, right arm). On 14 November 2013, 2 days after vaccination with ENGERIX B, the subject experienced runny nose and headache. On 20 November 2013, 8 days after vaccination with ENGERIX B, the subject experienced red, hot, swollen arm, painful six by eight inch swelling on right deltoid at injection that had pain shooting down arm site. The physician provided discrepant measurements during the report, he stated that the swelling measurements were six centimeters by seven centimeters and six by eight inches. The physician reported about a month later the subject continues to have painful six by eight inch swelling on right deltoid. The physician considered the events were disabling and clinically significant (or requiring intervention). It was unknown if the immunization series was delayed or discontinued. At the time of reporting the subject's runny nose and headache resolved; injection site redness and injection site warmth had improved. The injection site pain, pain shooting down arm and extensive swelling at vaccinated limb were worse. The lot number was reported as "AHBVC113" from the reporter; however, based on a safety lot number review, the lot number was updated to "AHBVC113AB". The physician also reported that the subject had a 'similar swelling' reaction years ago with tetanus portion of the Tdap (DTPa (with small D + P)); no further description provided. The specific details regarding the Tdap vaccination and the swelling reaction were not provided. The outcome of the swelling reaction was unknown.
Minimal pain on the injection Site After First Shot; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Minimal pain on the injection Site After First Shot) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Stent placement (Heart stent).   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced INJECTION SITE PAIN (Minimal pain on the injection Site After First Shot). In March 2021, INJECTION SITE PAIN (Minimal pain on the injection Site After First Shot) had resolved. Not Provided          No concomitant and treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-081717 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-081717:For first dose
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender who on 18-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (dose, route, lot # and expiration date were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a pharmacist referring to a female patient of unknown age. Her relevant medical history, relevant concomitant medications and past drug history are unknown. On an unknown date, two weeks ago in 2017, the patient received an unknown dose of ZOSTAVAX for prophylaxis. On 11-JUN-2017, the patient experienced stepped on a nail, so she would need to get a tetanus shot. Relevant lab data was unknown. As of 11-JUN-2017, it was unknown if the patient would get ZOSTAVAX again and the outcome of stepping on a nail was unknown. The lot number and expiration date were not requested because the pharmacist did not have time to provide any other information. The causality was not reported.
Patient was feeling dizzy, sweating and pale minutes after receiving vaccination.  Patient stated had not eaten since last night.  After providing a cold pack and orange juice patient was feeling better.  Followed up this afternoon and patient stated was feeling much better, was just having a headache. Advised if symptoms were worsening to seek medical attention
Patient's husband reports patient had chills, fever, and nausea in the evening the day of vaccination.  Patient went to bed and woke up the next day and told her husband she was still not feeling well.  At that time she also told him that she had been having trouble breathing the previous night.  The husband stated he was not sure if she was just having trouble catching her breath from shivering or if her airway was actually being affected.  The pharmacist advised the husband that if the patient is having trouble breathing at any time that she should seek immediate medical attention.  The husband said she was at home resting now but they would go see a doctor if she was having more trouble breathing or if symptoms got worse.
Pt was given a pneumonia vaccine (in hospital) via sq instead of IM - pt had severe reaction to vaccine. Entire red upper arm/warm to touch.
patient states she has had pain in her should since receiving the vaccine in october of 2021. states she is having trouble lifting things at work now.
fever noc of 16NOV93 asleep when had sz 15 seconds duration-eyes going back & forth extremities jerky-breathing funny then couldn't wake pt up-dx OM;
Increasing discomfort at injection site, red, hot, swelling, tender to touch.   Seen by Dr. on 9/22/09, three distinct areas of redness on right arm 7cm X 5cm,  3cm X 3cm, 1cm X 1cm.   Diagnosed with cellulitis and treated with Bactrim and Prednisone.
walked t car & convulsed-shook & leaned forward-blacked out & turned green;sat about 1min skin color then turned pale & felt nauseated;drove home;had bad h/a & sensitive to light & sound;
pt recv vax;subsequently exp local rash & severe tenderness at inject site;lethargy,fever of 100 & flu like sx;approx 3 days later sx resolved;2nd dose adm,following day, fever higher than 100 & flu like sx,lasted 4 days; recovered
I started having flu like symptoms: body aches, fever and sore throat. I just stayed home and stayed in bed. I was ill for about 3 weeks. I self treated with OTC medications.
After receiving tetanus on 02/28/2005, child woke up on morning of 03/01/2005 with complaints of neck pain, generalized pain, unable to walk, has been to ER and Dr office with no definate diagnosis.
approx 2 days after shot got dizzy  and has continued a little less each day.  Had to call ambulance for a check up but stayed home and continued to sit in chair and took blood pressure. 2nd day pressure was finally at 128/73.  dizziness was severe for a day where I couldn't  lay in a bed but felt better in a chair.  Called Doctor on 1-21-21 and was advised to take lots of liquids and get plenty of rest.
Urticaria/Hives neck back, abdomen arms and leg started 5/21/09 in the evening.  Treated with Zyrtec X 7 days.
11/9 - Aching all over - progressively worse numbness to palms of hands decreased pain mid back (three ER) 11/10 - ER - All digits and both feet tingling. Hard to walk - equilibrium off - constant pain 4/3/07 Received medical records from hospital which reveal patient experienced numbness of hands & feet w/weakness of LEs & unsteady gait worsening over about 1 week since receiving flu vax on 10/25.  Admitted to hospital 11/10/06-11/16/06.  Exam revealed decreased reflexes.  Tx w/IVIG over 5 days w/ improvement & d/c to rehab as outpatient. FINAL DX: Guillain Barre Syndrome.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, INJECTION SITE PAIN Narrative:
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. Concurrent conditions or pertinent medical history were not reported. On 18-NOV-2015, the patient was inadvertently administered with an expired dose of PNEUMOVAX 23 (lot # K007824, expiration date: 05-NOV-2015) intramuscularly (dose and frequency was unknown). Concomitant medications were not reported. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
About 36 hours after vaccine, pt reported fever of 101, mild chest pain, and dyspnea on exertion.  Advised rest and fluids
Extreme headache (migrane), dizziness, full body aches, heavy fatigue, racing heart, zero energy, red/sore/itchy eyes, fever and chills, sore throat, and cough.  *Symptoms carried over to 9/15/2011 causing me to call in sick for the day (9/15) missing work.  I was in bed all day (9/15) and did not feel any better until 8 p.m. the evening of 9/15.
On 8/1/23, Patent was due to receive the Dtap and Hib vaccines. However, he received two doses of Dtap in the forms of Daptacel and Pentacel. He did have the normal side-effect of fever, but did not suffer any adverse reactions to receiving the double dose of Dtap. We continued to follow-up with the family in the following days and next week and he continued to be free from any other reaction.
Started with chills at about 7pm my temperature started to rise.  In about an hour it was 103.4.  I took tylenol fever reducer at which time it started going down
Sore arm, A little tired after the first vaccine in May, very tired with some aches, chills and mild diarrhea with second vaccine, received yesterday afternoon. Felt great until 8:45 AM today which is the next day post vaccine.
Does not know if this was vaccine related or not, but patient had onset of GI bleeding and went to the ER. Got diagnosis of diverticulitis.
Fluid build up/knotting in bicep. Itching and discomfort. Still present as of 06/15/2013.
Driving home from doctors office after reciving flu shot got dizzy, made it home an passed out. Called doctor, drank water and ate saltines, then slept
ringing in ear; This case was reported by a consumer via call center representative and described the occurrence of ringing in ears in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On 6th January 2020, less than a week after receiving Shingrix, the patient experienced ringing in ears. The patient was treated with antibiotics nos, prednisone, otologicals (Ear Drops {Nos}), bioflavonoids (Flavonoid) and ginkgo biloba (Ginkobil). On an unknown date, the outcome of the ringing in ears was unknown.   It was unknown if the reporter considered the ringing in ears to be related to Shingrix.  Additional details were provided as follows: The patient experienced ringing in ears 5 to 7 days after receiving Shingrix vaccine. The patient tried 2 antibodics, prednisone pack , ear drops, Flavonoid & Ginko Biblio nothing had helped.
I can't say that I had an adverse reaction to the Covid10 shot. Only that I was sick from the end of May 2021 thru June 2021 with some sort of respiratory illness that took about a month to get better.  I took antibiotics and ended up in the ER as my doctor advised me to get check out to make sure I didn't have a blood clot in my lungs.
Information has been received from a physician concerning a 16 year old male patient who on 08-MAY-1996 was vaccinated with the first dose of MMR II.  The patient received the second dose of MMR II on 18-JUN-1997.  On 13-NOV-2009 the patient experienced mumps, (the date diagnosed was reported as 28-DEC-2009).  The patient had fever of 103 and had parotitis.  The outcome for mumps was not reported.   Follow up information has been received concerning the 16 year old male patient who on 08-MAY-1996 and on 18-JUN-1997 was vaccinated with the first and second doses of MMR II (route and lot # unknown), respectively.  On 06-NOV-2009 the patient experienced mumps (he was diagnosed on 08-NOV-2009).  The patient had fever of 102 and had L parotitis.  The patient also had cough and headaches.  On 08-NOV-2009,  a first blood work was performed:  IgM was negative, IgG was 198 and serum amylase was 359.  At the time of the report the patient's outcome was unknown.  No  further information is available.
Moderna rash/It was an inch away from the injection site, itchy, and about 2 inches by 2 inches; Moderna rash/It was an inch away from the injection site, itchy, and about 2 inches by 2 inches; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (Moderna rash/It was an inch away from the injection site, itchy, and about 2 inches by 2 inches) and VACCINATION SITE RASH (Moderna rash/It was an inch away from the injection site, itchy, and about 2 inches by 2 inches) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Moderna rash/It was an inch away from the injection site, itchy, and about 2 inches by 2 inches) and VACCINATION SITE RASH (Moderna rash/It was an inch away from the injection site, itchy, and about 2 inches by 2 inches). The patient was treated with CORTISONE for Itching, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Moderna rash/It was an inch away from the injection site, itchy, and about 2 inches by 2 inches) outcome was unknown and VACCINATION SITE RASH (Moderna rash/It was an inch away from the injection site, itchy, and about 2 inches by 2 inches) had resolved.            No concomitant medication was reported.  Patient had 3 series of an injection of Euflexxa in her knee, on 10 Oct 2022, 17 Oct 2022, and 24 Oct 2022.  Patient had to go to the emergency room on 25 Oct 2022 because she had a reaction to that third shot in her knee.  They tested patient's heart because she had shortness of breath. Blood pressure went up to 196/111.  Patient reported that she got the Moderna rash. One time it lasted a couple weeks. One time it lasted 1 week.
PT NOTICED RED PIMPLE LIKE RASH ON UPPER RIGHT ARM, SHOULDER, SHOULDER BLADE AND RIGHT BREAST.
MDV Polio (Ipol) was exposed to temperature excursion for 16 hours 54 minutes; Initial and additional (live-follow-up) information received on 16-May-2019 and 17-May-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves three patients who may have received vaccine IPV (VERO) [IPOL] (formulation: unknown, lot number not reported via unknown route in unknown administration site) on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to incorrect product storage (It was reported that the opened MDV Polio (IPOL) was exposed to temperature excursion for 16 hours 54 minutes)  It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.
Chills, fever, body ache, intense injection site pain, eye pain, dizziness, mild skin irritation throughout body, fatique
Fever and body aches starting at 10:00pm the day of vaccination and lasting for 24 hours. Fever reached 104 degrees Headache and fatigue 4 days Nausea lasting 1 day  Stomach pain and headache still happening (today is Monday, March 15th)
Patient reported that her throat was swollen and she was building up mucus and was had difficulty swallowing it.
Expired Vaccine. Per Pfizer this is ok if administered before 10/19/22. Patient is fine, does not need to be re vaccinated.
Persistent red itchy swollen rash in two patches on upper right arm, each about 2 inches by 2 inches. General feeling of itchiness all over body.
Flu shot 10/24/03 flu symptom 10/27 fever, cough, etc. FEver 1 day cough 1 wk. Flu shot in 2002-no r/u but cough/cold followed. Flu shot in 2001-no r/u but cough/cold followed. Follow up on 12/03/03: "you will have to get this info from the pharmacist wher ethe vaccine was administered."
Initial report received from a healthcare professional on 10 June 2013. A 22-year-old female patient whose concomitant medications were not reported, had received a subcutaneous dose of YF VAX vaccine (batch number - UH596AA, dose number-not reported) in left triceps and an intramuscular dose of MENACTRA vaccine (batch number-U4428AA, dose number-not reported) in right deltoid, both on 07 June 2013. The patient's pre-existing physician diagnosed allergies, birth defects and medical conditions include PMH Turner's syndrome. As per the reporter, the patient had no acute illness at time of vaccination. On 07 June 2013, the patient experienced a sense of light headedness and queasiness immediately post vaccination which resolved within 15 minutes. The corrective treatments were not reported and laboratory investigations were not done. On an unspecified date, the patient recovered from the events. Documents held by sender: none.
severe body aches, fever of +3-4 degrees above normal temp, chills, headache, burning eyes, disorientation.  This lasted for about 12-14 hours.